(Q37358922)

19 August 2017

1 reference

title

Beta-adrenergic stimulation and myocardial function in the failing heart (English)

1 reference

19 August 2017

Ali El-Armouche

1

1 reference

PubMed ID

19110970

19 August 2017

Thomas Eschenhagen

series ordinal

2

1 reference

19 August 2017

1 December 2009

1 reference

19 August 2017

Heart Failure Reviews

1 reference

19 August 2017

14

1 reference

19 August 2017

225-241

1 reference

19 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-008-9132-8

19 August 2017

0 references

cites work

G-protein coupled receptor signaling in myocardium: not for the faint of heart.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Cyclic nucleotide-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Myocardial cyclic AMP and norepinephrine content in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Altered cardiac myocyte Ca regulation in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-008-9132-8

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

12 December 2020

Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure

1 reference

12 December 2020

CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

1 reference

12 December 2020

Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.

1 reference

12 December 2020

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

1 reference

12 December 2020

Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.

1 reference

12 December 2020

Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.

1 reference

12 December 2020

Cardiac HCN channels: structure, function, and modulation

1 reference

12 December 2020

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment

1 reference

12 December 2020

Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase

1 reference

12 December 2020

Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury

1 reference

12 December 2020

Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.

1 reference

12 December 2020

Targeting phospholamban by gene transfer in human heart failure

1 reference

12 December 2020

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes

1 reference

12 December 2020

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

1 reference

12 December 2020

What is the role of beta-adrenergic signaling in heart failure?

1 reference

12 December 2020

Alterations of calcium-regulatory proteins in heart failure.

1 reference

12 December 2020

beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes

1 reference

12 December 2020

Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy

1 reference

12 December 2020

Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium

1 reference

12 December 2020

Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress.

1 reference

12 December 2020

Cardiomyopathy induced by cardiac Gs alpha overexpression

1 reference

12 December 2020

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

12 December 2020

Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.

1 reference

12 December 2020

Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban

1 reference

12 December 2020

Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice

1 reference

12 December 2020

Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure

1 reference

12 December 2020

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart

1 reference

12 December 2020

Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice

1 reference

12 December 2020

A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors

1 reference

12 December 2020

Regulation of ryanodine receptors in the heart.

1 reference

12 December 2020

Calcium cycling in congestive heart failure

1 reference

12 December 2020

(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling

1 reference

12 December 2020

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

1 reference

12 December 2020

Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias.

1 reference

12 December 2020

Seven-transmembrane-spanning receptors and heart function

1 reference

12 December 2020

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

1 reference

12 December 2020

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure

1 reference

12 December 2020

G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure

1 reference

12 December 2020

Increase in myocardial Gi-proteins in heart failure

1 reference

12 December 2020

Regulation of the human Gi alpha-2 gene promotor activity in embryonic chicken cardiomyocytes

1 reference

12 December 2020

Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor

1 reference

12 December 2020

Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins

1 reference

12 December 2020

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

1 reference

12 December 2020

Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].

1 reference

12 December 2020

Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors

1 reference

12 December 2020

Type 5 adenylyl cyclase disruption increases longevity and protects against stress

1 reference

12 December 2020

Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms.

1 reference

12 December 2020

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak

1 reference

12 December 2020

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

1 reference

12 December 2020

Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes

1 reference

12 December 2020

Type 1 phosphatase, a negative regulator of cardiac function

1 reference

12 December 2020

Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers

1 reference

12 December 2020

Protein phosphatase 1--targeted in many directions

1 reference

12 December 2020

The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly

1 reference

12 December 2020

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy

1 reference

12 December 2020

Adrenergic and muscarinic receptors in the human heart

1 reference

12 December 2020

Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory

1 reference

12 December 2020

Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse

1 reference

12 December 2020

Cardiac excitation-contraction coupling

1 reference

12 December 2020

Cardiac adrenoceptors: physiological and pathophysiological relevance

1 reference

12 December 2020

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes

1 reference

12 December 2020

AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum

1 reference

12 December 2020

The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

1 reference

12 December 2020

Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.

1 reference

12 December 2020

Gi/o signaling and its potential role in cardioprotection

1 reference

12 December 2020

Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms

1 reference

12 December 2020

Modulation of cardiac function by A-kinase anchoring proteins

1 reference

12 December 2020

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

12 December 2020

Adenylyl cyclase increases survival in cardiomyopathy

1 reference

12 December 2020

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

12 December 2020

Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure

1 reference

12 December 2020

Phospholamban: protein structure, mechanism of action, and role in cardiac function

1 reference

12 December 2020

Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy

1 reference

12 December 2020

Mechanisms and models in heart failure: the biomechanical model and beyond

1 reference

12 December 2020

Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle

1 reference

12 December 2020

Overexpression of Gs alpha protein in the hearts of transgenic mice

1 reference

12 December 2020

How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH

1 reference

12 December 2020

Reversing chronic remodeling in heart failure

1 reference

12 December 2020

Effects of serine/threonine protein phosphatases on ion channels in excitable membranes

1 reference

12 December 2020

Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart.

1 reference

12 December 2020

Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression

1 reference

12 December 2020

Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition

1 reference

12 December 2020

Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias

1 reference

12 December 2020

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

1 reference

12 December 2020

Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice.

1 reference

12 December 2020

Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts

1 reference

12 December 2020

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

12 December 2020

Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation

1 reference

12 December 2020

Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice

1 reference

12 December 2020

Structure and function of the beta 3-adrenergic receptor

1 reference

12 December 2020

Cardiac myosin-binding protein C in the heart.

1 reference

12 December 2020

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

1 reference

12 December 2020

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

1 reference

12 December 2020

Cardiac protein phosphorylation: functional and pathophysiological correlates

1 reference

12 December 2020

Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

1 reference

12 December 2020

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

1 reference

12 December 2020

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

12 December 2020

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure

1 reference

12 December 2020

Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart

1 reference

12 December 2020

Current role of beta-adrenergic blockers in the management of chronic heart failure

1 reference

12 December 2020

Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias

1 reference

12 December 2020

Na/Ca exchange: regulator of intracellular calcium and source of arrhythmias in the heart.

1 reference

12 December 2020

Cardioprotection specific for the G protein G i2 in chronic adrenergic signaling through β 2 -adrenoceptors

1 reference

12 December 2020

New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy

1 reference

12 December 2020

Functional diversity of protein phosphatase-1, a cellular economizer and reset button

1 reference

12 December 2020

Calcium cycling and signaling in cardiac myocytes.

1 reference

12 December 2020

Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice

1 reference

12 December 2020

Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac

1 reference

12 December 2020

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

1 reference

12 December 2020

Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy

1 reference

12 December 2020

Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.

1 reference

12 December 2020

Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation

1 reference

12 December 2020

Troponin I phosphorylation in the normal and failing adult human heart

1 reference

12 December 2020

Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure?

1 reference

12 December 2020

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

1 reference

12 December 2020

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

12 December 2020

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

1 reference

12 December 2020

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

1 reference

12 December 2020

Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart

1 reference

12 December 2020

Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration

1 reference

12 December 2020

Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?

1 reference

12 December 2020

beta-Adrenergic receptors, transgenic mice, and pharmacological model systems.

1 reference

12 December 2020

Increased expression of cardiac phosphatases in patients with end-stage heart failure

1 reference

12 December 2020

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol

1 reference

12 December 2020

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

1 reference

12 December 2020

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart

1 reference

12 December 2020

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

1 reference

12 December 2020

Pathological autoantibodies in cardiomyopathy.

1 reference

12 December 2020

Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.

1 reference

12 December 2020

Is depressed myocyte contractility centrally involved in heart failure?

1 reference

12 December 2020

Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure

1 reference

12 December 2020

Manipulating cardiac contractility in heart failure: data from mice and men.

1 reference

12 December 2020

Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure

1 reference

12 December 2020

Myocyte adrenoceptor signaling pathways

1 reference

12 December 2020

Phospholamban: a crucial regulator of cardiac contractility

1 reference

12 December 2020

Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses

1 reference

12 December 2020

Tackling heart failure in the twenty-first century

1 reference

12 December 2020

Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts

1 reference

12 December 2020

Beta-adrenergic signaling in heart failure-adapt or die.

1 reference

12 December 2020

Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP.

1 reference

12 December 2020

Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis

1 reference

12 December 2020

Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy

1 reference

12 December 2020

Cross-regulation between G-protein-mediated pathways. Activation of the inhibitory pathway of adenylylcylclase increases the expression of beta 2-adrenergic receptors

1 reference

12 December 2020

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

12 December 2020

Calcium, thin filaments, and the integrative biology of cardiac contractility

1 reference

12 December 2020

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

1 reference

12 December 2020

Small GTP-binding proteins and their regulators in cardiac hypertrophy

1 reference

12 December 2020

cAMP-binding protein Epac induces cardiomyocyte hypertrophy.

1 reference

12 December 2020

Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice

1 reference

12 December 2020

G proteins and the heart

1 reference

12 December 2020

Re-evaluating sarcoplasmic reticulum function in heart failure

1 reference

12 December 2020

Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure

1 reference

12 December 2020

Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium

1 reference

12 December 2020

Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1

1 reference

12 December 2020

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation

1 reference

12 December 2020

10.1007/S10741-008-9132-8

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19110970